Diagnosing COVID-19: “Did We Miss Anything?”
In late 2019, a mass of patients showing symptoms of a pneumonia-like disease of unknown origin emerged in Wuhan, China. Little did the world know it was the prelude of what would be a devastating pandemic. Samples were collected from these patients and the use of unbiased sequencing, and subsequent...
Main Authors: | Eric Daniel Tenda, Moses Mazmur Asaf |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2020-04-01
|
Series: | Acta Medica Indonesiana |
Subjects: | |
Online Access: | http://actamedindones.org/index.php/ijim/article/view/1425 |
Similar Items
-
Metabolomic Biomarkers to Predict and Diagnose Cystic Fibrosis Pulmonary Exacerbations: A Systematic Review
by: Anna-Lisa V. Nguyen, et al.
Published: (2022-05-01) -
Arterialised Capillary Blood Gases in Accident and Emergency Department Patients - a Reliable Alternative to Arterial Sampling?
by: Faheem Shakur, et al.
Published: (2020-12-01) -
Response of Very Premature Infants with Bronchopulmonary Dysplasia to Inhaled Salbutamol
by: Ha-Nam Nguyen, et al.
Published: (2020-12-01) -
The Importance of Chest CT Scan in COVID-19
by: Eric Daniel Tenda, et al.
Published: (2020-04-01) -
The COVID-19 surge in Indonesia: what we learned and what to expect
by: Eric Daniel Tenda, et al.
Published: (2021-12-01)